Recent progression in MXene-based catalysts for emerging photocatalytic applications of CO reduction and H production: A review.

Sci Total Environ

Department of Chemistry, Biochemistry, and Physics, Université du Québec à Trois-Rivières (UQTR), 3351 Boulevard des Forges, Trois-Rivières, QC G8Z 4M3, Canada; Laboratory of Advanced Materials for Energy and Environment, Université du Québec à Trois-Rivières (UQTR), 3351 Boulevard des Forges, Trois-Rivières, QC G8Z 4M3, Canada. Electronic address:

Published: June 2024

The development of advanced materials for efficient photocatalytic H production and CO reduction is highly recommended for addressing environmental issues and producing clean energy sources. Specifically, MXenes have emerged as two-dimensional (2D) materials extensively used as high-performance cocatalysts in photocatalyst systems owing to their outstanding features of structure and properties such as high conductivity, large specific surface area, and abundant active sites. Nevertheless, there is a lack of deep and systematic studies concerning the application of these emerging materials for CO reduction reaction (CRR) and H production (HER). This review first outlines the essential features of MXenes, encompassing the synthesis methods, composition, surface terminations, and electronic properties, which make them highly active as cocatalysts. It then examines the recent progress in MXene-based photocatalysts, emphasizing the synergy achieved by coupling MXenes as co-catalysts with semiconductors, utilizing MXenes as a support for the consistent growth of photocatalysts, leading to finely dispersed nanoparticles, and exploiting MXene as exceptional precursors for creating MXene/metal oxide photocomposite. The roles of engineering surface terminations of MXene cocatalysts, MXene quantum dots (QDs), and distinctive morphologies in MXenes-based photocatalyst systems to enhance photocatalytic activity for both HER and CRR have been explored both experimentally and theoretically using DFT calculations. Challenges and prospects for MXene-based photocatalysts are also addressed. Finally, suggestions for further research and development of effective and economical MXenes/semiconductors strategies are proposed. This comprehensive review article serves as a valuable reference for researchers for applying MXenes in photocatalysis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scitotenv.2024.172816DOI Listing

Publication Analysis

Top Keywords

production review
8
photocatalyst systems
8
surface terminations
8
mxene-based photocatalysts
8
mxenes
5
progression mxene-based
4
mxene-based catalysts
4
catalysts emerging
4
emerging photocatalytic
4
photocatalytic applications
4

Similar Publications

Purpose: To assess and compare the diagnostic efficiency of histogram analysis of monochromatic and iodine images derived from spectral CT in predicting Ki-67 expression in gastric gastrointestinal stromal tumors (gGIST).

Methods: Sixty-five patients with gGIST who underwent spectral CT were divided into a low-level Ki-67 expression group (LEG, Ki-67 < 10%, n = 33) and a high-level Ki-67 expression group (HEG, Ki-67 ≥ 10%, n = 32). Conventional CT features were extracted and compared.

View Article and Find Full Text PDF

Superior persistence of ustekinumab compared to anti-TNF in vedolizumab-experienced inflammatory bowel diseases patients: a real-world cohort study.

BMC Gastroenterol

December 2024

Department of Gastroenterology and Hepatology, Linkou Branch, Chang Gung Memorial Hospital, 5, Fu-Hsin Street, Guei-Shan District, Taoyuan, 33305, Taiwan.

Background/aims: The increasing use of biologic therapies for moderate to severe inflammatory bowel disease (IBD) highlights the importance of optimal treatment sequencing, particularly after vedolizumab (VDZ) exposure. Studies comparing the effectiveness of ustekinumab (UST) and antitumor necrosis factor (anti-TNF) agents post-VDZ are limited.

Methods: This retrospective study analyzed VDZ-experienced IBD patients treated with UST or anti-TNF (adalimumab and infliximab) from May 2019 to January 2024.

View Article and Find Full Text PDF

High altitudes, deeper insights: multicenter cardiovascular magnetic resonance study on hypertrophic cardiomyopathy.

Eur Radiol

December 2024

The First Clinical Medical College of Lanzhou University, Department of Radiology, The First Hospital of Lanzhou University, Intelligent Imaging Medical Engineering Research Center of Gansu Province, Accurate Image Collaborative Innovation International Science and Technology Cooperation Base of Gansu Province, Gansu Province Clinical Research Center for Radiology Imaging, Lanzhou, China.

Objectives: Altitude is a known factor in cardiovascular disease, but its impact on hypertrophic cardiomyopathy (HCM) patients remains unclear. This study aimed to determine whether living at high altitudes affects the extent of late gadolinium enhancement (LGE) and left ventricular (LV) strain in HCM patients.

Methods: This retrospective cross-sectional study was conducted across four hospitals located at different altitudes in China.

View Article and Find Full Text PDF

Objectives: We report our experience implementing an algorithm for the detection of large vessel occlusion (LVO) for suspected stroke in the emergency setting, including its performance, and offer an explanation as to why it was poorly received by radiologists.

Materials And Methods: An algorithm was deployed in the emergency room at a single tertiary care hospital for the detection of LVO on CT angiography (CTA) between September 1st-27th, 2021. A retrospective analysis of the algorithm's accuracy was performed.

View Article and Find Full Text PDF

NRP1 instructs IL-17-producing ILC3s to drive colitis progression.

Cell Mol Immunol

January 2025

Department of oncology, The Second Hospital of Tianjin Medical University; Tianjin Key Laboratory of Precision Medicine for Sex Hormones and Diseases; Tianjin Institute of Immunology, Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.

Group 3 innate lymphoid cells (ILC3s) control tissue homeostasis and orchestrate mucosal inflammation; however, the precise mechanisms governing ILC3 activity are fully understood. Here, we identified the transmembrane protein neuropilin-1 (NRP1) as a positive regulator of interleukin (IL)-17-producing ILC3s in the intestine. NRP1 was markedly upregulated in intestinal mucosal biopsies from patients with inflammatory bowel disease (IBD) compared with healthy controls.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!